510(k) Report

510(k) · Cleared

Recalled · 2008

Tevadaptor, Closed Drug Reconstitution and Transfer System

K071741510(k) TraditionalCleared Sep 24, 200789-day reviewClass II21 CFR 880.5440Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Migada Plant · LHI Set, I.V. Fluid Transfer

Cleared on Sep 24, 2007 as substantially equivalent to K980381 (Carmel Pharma Ab., 1998) after an 89-day review. Its family tree reaches back 3 generations to 1988. 11 later devices descend from it. It has been recalled once.

Decided
Sep 24, 2007
Review
89 days
Class
Class II
Product code
LHI
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K883614 (1988). 5 ancestors in all. 11 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor1994: 1 other ancestor2014: 1 descendant cleared2015: 1 descendant cleared2017: 1 descendant cleared2020: 1 descendant cleared2018: 1 descendant cleared2021: 2 descendants cleared2023: 1 descendant cleared2025: 2 descendants cleared2024: 1 descendant clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 4 descendants3 generations forward: 5 descendants K980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 1998K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880
  1. Root · 3 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 2 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 1 generation backK980381 Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab. · 1998
  4. This deviceK071741 Tevadaptor, Closed Drug Reconstitution and Transfer SystemMigada Plant · 2007
  5. Descendant · cites it directly · 9 of its ownK141448 Tevadaptor Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant · 2015
  6. Descendant · 2 generations on · 3 of its ownK192866 Chemfort CSTDSimplivia Healthcare, Ltd. · 2020 · Recalled
  7. Descendant · 2 generations on · 1 of its ownK201422 Arisure Closed System Drug Transfer Device (CSTD)Yukon Medical, LLC · 2021
  8. Descendant · 2 generations on · 1 of its ownK180489 TEVADAPTOR Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant · 2018
  9. Descendant · 3 generations on · 0 of its ownK253033 Chemfort® 28-day 20 mm Vial Adaptor and 13 mm ConvertorSimplivia Healthcare, Ltd. · 2025

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2014: 12015: 12017: 12018: 12020: 12021: 22023: 12024: 12025: 2
2014high 2 (2021) · low 0 (2016)2026

Most influential descendants

Showing 5 of 11 · See all
  • K141448Tevadaptor Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant · 2015 · cites it directly9descendants
  • K192866Chemfort CSTDSimplivia Healthcare, Ltd. · 2020 · 2 generations on3descendants
  • K201422Arisure Closed System Drug Transfer Device (CSTD)Yukon Medical, LLC · 2021 · 2 generations on1descendant
  • K180489TEVADAPTOR Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant · 2018 · 2 generations on1descendant
  • K253033Chemfort® 28-day 20 mm Vial Adaptor and 13 mm ConvertorSimplivia Healthcare, Ltd. · 2025 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K883614Cytoguard (R)Survival Technology, Inc.1988—
−2K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−1K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab.1998—
0 (this device)K071741Tevadaptor, Closed Drug Reconstitution and Transfer SystemMigada Plant2007—
+1K141448Tevadaptor Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant2015—
+2K192866Chemfort CSTDSimplivia Healthcare, Ltd.20201
+2K201422Arisure Closed System Drug Transfer Device (CSTD)Yukon Medical, LLC2021—
+2K180489TEVADAPTOR Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant2018—
+3K253033Chemfort® 28-day 20 mm Vial Adaptor and 13 mm ConvertorSimplivia Healthcare, Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201510
201710
201810
202010
202120
202310
202410
202520
FIG. 1 — Lineage of K071741, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LHI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHI device

  1. #1 K252987 ADRx™ Admixture Devicescore 12.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration…
Summary page 2
…l® closed system for the preparation and administration of parenteral drugs, Carmel Pharna AB, S-402 28 Gottingen, Sweden, cleared under 510(k) no. K980381. Description of the device: The device comprises of the following components: -…
Carmel Pharma Ab.1998—

Also cleared against K980381: 6 other devices →

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141448Tevadaptor Closed Drug Reconstitution and Transfer SystemTeva Medical Ltd., Migada Plant20159
K132011Apoteca Dug Compounding Dosing Device,Apoteca I.V. Transfer SetAea Srl20140

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 18, 2008Not classifiedZ-1244-2009Component design/selectionSyringe adaptor is disintegrating when attached to the end of the syringe.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 4 companies; a new generation was cleared every 9.0 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K141448 (Teva Medical Ltd., Migada Plant, 2015) has gone furthest, with 9 descendants of its own.
  • 6 other devices also cite its predicate K980381.

How does its category compare?

All LHI devices

LHI Set, I.V. Fluid Transfer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LHI

6in 2025

2007: 32008: 42009: 82010: 52011: 32012: 52013: 42014: 62015: 32016: 32017: 52018: 12019: 42020: 32021: 32022: 62023: 52024: 92025: 62026 (partial year): 2
2007high 9 (2024) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHI

196in 2025

2007: 89 days median2008: 154 days median2009: 95 days median2010: 139 days median2011: 99 days median2012: 127 days median2013: 102 days median2014: 63 days median2015: 99 days median2016: 159 days median2017: 56 days median2019: 247 days median2020: 189 days median2021: 396 days median2022: 278 days median2023: 90 days median2024: 166 days median2025: 196 days median
2007high 396 (2021) · low 56 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LHI

1in 2024

2007: 12008: 32009: 12010: 32011: 122013: 32016: 1, 1 Class I2017: 12018: 3, 3 Class I2019: 12022: 22023: 2, 2 Class I2024: 12026 (partial year): 1
2007high 12 (2011) · low 0 (2012)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · LHI

1,334in 2025

2007: 182008: 272009: 372010: 492011: 1552012: 5292013: 1542014: 1552015: 1282016: 2192017: 5362018: 1,4992019: 1,6342020: 1,1712021: 9332022: 1,8342023: 1,0472024: 1,2702025: 1,334
2007high 1,834 (2022) · low 18 (2007)2025

MAUDE reports naming product code LHI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389118
20084154327
2009895137
20105139349
201139912155
201251270529
201341023154
20146630155
20153990128
201631591 (1)219
20175561536
20181—3 (3)1,499
2019424711,634
2020318901,171
202133960933
2022627821,834
20235902 (2)1,047
2024916611,270
2025619601,334
20262—1—

What is it indicated for?

The TEVADAPTOR M, Closed Drug Reconstitution and Transfer System is a closed system to be used by pharmacists or other healthcare professionals to prepare drugs, including cytotoxic drugs, for intravenous infusion or injection.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071741: Tevadaptor, Closed Drug Reconstitution and Transfer System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071741

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026